Metraipolis › archive › dc_88bd50cb92ce
Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection — Europe PMC PMID:41512000
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41512000
- DOI
- 10.1371/journal.pntd.0013597
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T23:02:23.136Z
- SHA-256 of the archived text
3655003c257f44f19958f650adf914609bbf231b71f05ba1a1abe5634ebf25a7- Stable URL of this page
https://metraipolis.com/documento/dc_88bd50cb92ce
How to cite
Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection — Europe PMC PMID:41512000 — Europe PMC (en), https://europepmc.org/article/MED/41512000 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_88bd50cb92ce (Metraipolis archive dc_88bd50cb92ce, sha256 3655003c257f44f19958f650adf914609bbf231b71f05ba1a1abe5634ebf25a7)
BibTeX
@misc{dc88bd50cb92ce,
title = {Target product profile for the development of pediatric formulations of new drugs for the treatment of children with T. cruzi infection — Europe PMC PMID:41512000},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41512000},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_88bd50cb92ce; sha256 3655003c257f44f19958f650adf914609bbf231b71f05ba1a1abe5634ebf25a7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41512000. Agents can read the archived copy with the MCP tool read_document.